Motif Bio PLC (LON:MTFB)

Motif Bio PLC (LON:MTFB)

Share Price
7.70 p
0.49 (6.80 %)
Market Cap
£26.37 m
Proactive Investors - Run By Investors For Investors

Motif Bio PLC

Motif Bio PL (LON:MTFB, NASDAQ:MTFB) is a clinical-stage biopharmaceutical company focused on developing novel antibiotics designed to be effective against serious and life-threatening infections caused by multi-drug resistant Gram-positive bacteria, including MRSA.

The company’s lead product candidate is iclaprim. Motif Bio is seeking approval of iclaprim from the U.S. Food & Drug...

Market: AIM:MTFB
52-week High/Low: 44.90p / 4.75p
Sector: Pharma & Biotech
Market Cap: £26.37 m
col 3
col 4
col 5
col 6

© Proactive Investors 2019

Proactive Investors Limited, trading as “Proactiveinvestors United Kingdom”, is Authorised and regulated by the Financial Conduct Authority.
Registered in England with Company Registration number 05639690. Group VAT registration number 872070825 FCA Registration number 559082. You can contact us here.

Market Indices, Commodities and Regulatory News Headlines copyright © Morningstar. Data delayed 15 minutes unless otherwise indicated. Terms of use